LG G Pad F 8.0" 2nd Gen ACG Owners Manual - Page 104

National Institute for Occupational Safety and Health

Get LG G Pad F 8.0inch 2nd Gen ACG PDF manuals and user guides View all LG G Pad F 8.0" 2nd Gen ACG manuals
Add to My Manuals
Save this manual to your list of manuals

Page 104 highlights

a level that is hazardous to the user. In such a case, the FDA could require the manufacturers of tablets to notify users of the health hazard and to repair, replace, or recall the tablets so that the hazard no longer exists. Although the existing scientific data does not justify FDA regulatory actions, the FDA has urged the tablet industry to take a number of steps, including the following: A Support needed research into possible biological effects of RF of the type emitted by tablets; A Design tablets in a way that minimizes any RF exposure to the user that is not necessary for device function; and A Cooperate in providing users of tablets with the best possible information on possible effects of tablet use on human health. The FDA belongs to an interagency working group of the federal agencies that have responsibility for different aspects of RF safety to ensure coordinated efforts at the federal level. The following agencies belong to this working group: A National Institute for Occupational Safety and Health A Environmental Protection Agency A Occupational Safety and Health Administration A National Telecommunications and Information Administration The National Institutes of Health participates in some interagency working group activities, as well. The FDA shares regulatory responsibilities for tablets with the Federal Communications Commission (FCC). All tablets that are sold in the United States must comply with FCC safety guidelines that limit RF exposure. The FCC relies on the FDA and other health agencies for safety questions about tablets. The FCC also regulates the base stations that the tablet networks rely upon. While these base stations operate at higher power than do the tablets themselves, the RF exposures that people get from these base stations are typically thousands of times lower than those they can get from tablets. Base stations are thus not the subject of the safety questions discussed in this document. For Your Safety 103

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
For Your Safety
103
a level that is hazardous to the user. In such a case, the FDA could require
the manufacturers of tablets to notify users of the health hazard and to
repair, replace, or recall the tablets so that the hazard no longer exists.
Although the existing scientific data does not justify FDA regulatory
actions, the FDA has urged the tablet industry to take a number of steps,
including the following:
Support needed research into possible biological effects of RF of the
type emitted by tablets;
Design tablets in a way that minimizes any RF exposure to the user
that is not necessary for device function; and
Cooperate in providing users of tablets with the best possible
information on possible effects of tablet use on human health.
The FDA belongs to an interagency working group of the federal agencies
that have responsibility for different aspects of RF safety to ensure
coordinated efforts at the federal level. The following agencies belong to
this working group:
National Institute for Occupational Safety and Health
Environmental Protection Agency
Occupational Safety and Health Administration
National Telecommunications and Information Administration
The National Institutes of Health participates in some interagency
working group activities, as well.
The FDA shares regulatory responsibilities for tablets with the Federal
Communications Commission (FCC). All tablets that are sold in the United
States must comply with FCC safety guidelines that limit RF exposure.
The FCC relies on the FDA and other health agencies for safety questions
about tablets.
The FCC also regulates the base stations that the tablet networks rely
upon. While these base stations operate at higher power than do the
tablets themselves, the RF exposures that people get from these base
stations are typically thousands of times lower than those they can
get from tablets. Base stations are thus not the subject of the safety
questions discussed in this document.